Back to Search
MICHAEL WEBER, MD
MD
Specialist
NPI: 1346472792Individual
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
126724-1(NY)
Research & Publications (20)
Achieving blood pressure goals: should angiotensin II receptor blockers become first-line treatment in hypertension?
PMID 19587555·J Hypertens Suppl·2009
6-review
Treatment of patients with hypertension and arthritis pain: new concepts.
PMID 19393822·Am J Med·2009
6-review
Beta-blockers in the treatment of hypertension: new data, new directions.
PMID 18326967·J Clin Hypertens (Greenwich)·2008
8-other
First-step use of fixed-dose combination treatment in stage 2 hypertensive patients: has the time come?
PMID 17396071·J Clin Hypertens (Greenwich)·2007
8-other
New opportunities in cardiovascular patient management: a survey of clinical data on the combination of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
PMID 17666198·Am J Cardiol·2007
6-review
Expanding the opportunities for blocking the renin-angiotensin system: introduction to a special supplement.
PMID 17401311·Rev Cardiovasc Med·2007
6-review
Hypertension treatment and implications of recent cardiovascular outcome trials.
PMID 16601560·J Hypertens Suppl·2006
6-review
Efficacy of a once-daily formulation of carvedilol for the treatment of hypertension.
PMID 17170609·J Clin Hypertens (Greenwich)·2006
4-observational
Controlled-release carvedilol in the treatment of essential hypertension.
PMID 17023230·Am J Cardiol·2006
2-rct
Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: do we need a more comprehensive strategy?
PMID 16915123·Rev Cardiovasc Med·2006
6-review
The role of the new beta-blockers in treating cardiovascular disease.
PMID 16373195·Am J Hypertens·2005
4-observational
Angiotensin-II receptor blockers for hypertension and heart failure: quality of life and outcomes.
PMID 15766065·Manag Care Interface·2005
8-other
Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial.
PMID 15207957·Lancet·2004
4-observational
Screening for lung cancer with computed tomography: an examination of the evidence.
PMID 15357166·JAAPA·2004
6-review
Evaluation of the 24 h effects of the angiotensin II receptor blockers: means to improve cardiovascular outcomes?
PMID 14624172·Blood Press Monit·2003
6-review
Angiotensin II receptor blockers and cardiovascular outcomes: what does the future hold?
PMID 12806587·J Renin Angiotensin Aldosterone Syst·2003
6-review
The telmisartan programme of research tO show Telmisartan End-organ proteCTION (PROTECTION) programme.
PMID 14513950·J Hypertens Suppl·2003
6-review
Introduction: the hemodynamic and vascular effects of angiotensin II: managing the consequences.
PMID 11824871·Am J Hypertens·2002
8-other
Calcium channel antagonists in the treatment of hypertension.
PMID 14727956·Am J Cardiovasc Drugs·2002
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 910 5TH AVE, APT. 6A
NEW YORK, NY 10021 - Phone
- (212) 584-9191
Quick Facts
- NPI
- 1346472792
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile